Outcome of Board Meeting

UNICHEMI LABORATORIES LTD. ~=----i 4th November 2026 Department of Corporate Services National Stock Exchange of India, BSE Limited, Exchange Plaza, Phiroze Jeejeebhoy Towers, Bandra Kurla Complex, Dalal Street, Mumbai – 400 001 Bandra (East), Mumbai – 400 051 Script Code: 506690 Symbol: UNICHEMLAB Dear Sir/Madam, Sub: Outcome of Board Meeting We would like to inform you that the Board of Directors at its Meeting held today, i.e. Wednesday, 4th November 2026 approved Unaudited Financial Statements (Consolidated & Standalone) for the second quarter and half year ended 30th September 2026. Enclosed herewith are the Unaudited Financial Statements (Consolidated & Standalone) for the second quarter and half year ended 30th September 2026 along with Limited Review report by Auditors. The Board meeting commenced at 11:30 a.m. and concluded at 01:45 p.m. The same will also be made available on the Company’s website www.unichemlabs.com as well as on www.bseindia.com and www.nseindia.com. Kindly take the same on your records.5 Thanking you, FOR UNICHEM LABORATORIES LIMITED PRADEEP BHANDARI Head – Legal & Company Secretary Encl.: a/a Registered Office: 47, Kandivli Industrial Estate, Kandivli (West), Mumbai - 400 067 Maharashtra, India. Tel.:+91 (22) 66474100 · Website:www.unichemlabs.com · CIN: L99999MH1962PLC012451 UNICHEM LABORATORIES LIMITED Regd. Office: 47, Kandivli Industrial Estate, Kandivli (West), Mumbai 400 067, Maharashtra, India. Tel: +91(22)66474100. Website: www.unichemlabs.com. GIN: L99999MH1962PLC012451 Statement of Consolidated Unaudited Financial Results for the Quarter and Half Year ended 30th September 2026 f Crores Quarter ended Half year ended Year ended 30.09.2026 30.06.2026 30.09.2025 30.09.2026 30.09.2025 31.03.2026 Particulars Unaudited Unaudited Unaudited Unaudited Unaudited Audited I Revenue from operations 640.22 632.62 578.96 1,272.84 1,105.56 2,201.85 II Other income 15.37 15.61 20.97 30.98 27.79 63.06 Ill Total income (1+11) 655.59 648.23 599.93 1,303.82 1,133.35 2,264.91 IV EXPENSES Cost of materials consumed 255.11 190.02 193.06 445.13 410.54 768.83 Purchase of stock-in-trade 68.17 67.25 39.76 135.42 90.77 231.51 Changes in inventories of stock-in-trade, finished goods and work-in- (52.79) 31.32 37.56 (21.47) 14.12 20.21 progress Employee benefits expense (Refer note 6) 105.57 103.31 100.13 208.88 207.55 396.63 Finance costs 7.71 6.62 8.24 14.33 14.78 31.59 Depreciation and amortization expenses 30.49 29.94 31.47 60.43 63.26 125.12 Other expenses 189.70 170.78 142.27 360.48 293.91 600.50 Total expenses (IV) 603.96 599.24 552.49 1,203.20 1,094.93 2,174.39 V Share of profit/ (loss) in associate (net of tax) - - - - - - VI Profit/ (Loss) before exceptional items and tax (111-IV+V) 51.63 48.99 47.44 100.62 38.42 90.52 VII Exceptional items -expenses/(income) (Refer note 5) 24.26 - 58.26 24.26 58.26 (201.86) VIII Profit I (Loss) before tax (VI-VII) 27.37 48.99 (10.82) 76.36 (19.84) 292.38 IX Tax expense (Refer note 4) (1) Current tax 1.76 0.72 0.98 2.48 1.94 3.57 (2) Deferred tax charge/ (credit) 3.39 6.80 0.09 10.19 0.14 35.53 (3) Short/ (excess) provision for tax (earlier years) - - - - 0.44 0.44 5.15 7.52 1.07 12.67 2.52 39.54 X Profit I (Loss) for the period after tax (VIII-IX) 22.22 41.47 (11.89) 63.69 (22.36) 252.84 XI Other Comprehensive Income/ (Loss) A (i) Items that will not be reclassified subsequently to profit or loss -Remeasurement of the net defined benefit plan 3.37 0.28 1.14 3.65 6.01 10.15 (ii) Income tax (expense) / credit relating to items that will not be reclassified to profit or loss -Remeasurement of the net defined benefit plan (0.85) (0.07) - (0.92) - (2.55) B. (i) Items that will be reclassified to profit or loss (Foreign currencv translation difference) -Foreign currency translation difference 0.68 (3.27) 0.71 (2.59) (1.11) 4.39 (ii) Income tax relating to items that will be reclassified to profit or loss -Foreign currency translation difference - - - - - - Total of Other Comprehensive Income/ (Loss) 3.20 (3.06) 1.85 0.14 4.90 11.99 XII Total Comprehensive lncome/(loss) for the period (X+XI) 25.42 38.41 (10.04) 63.83 (17.46) 264.83 XIII Paid-up equity share capital (Face value of~ 2/-per share) 14.08 14.08 14.08 14.08 14.08 14.08 XIV Other Equity (Reserves excluding revaluation reserve) 2,688.66 xv Earnings per equity share (Face value of~ 2/-per share) (not annualized) (1) Basic 3.16 5.89 (1.69) 9.05 (3.18) 35.91 (2) Diluted 3.14 5.89 (1.69) 9.03 (3.18) 35.85 UNICHEM UNICHEM LABORATORIES LIMITED Regd. Office: 47, Kandivli Industrial Estate, Kandivli (West), Mumbai 400 067, Maharashtra, India. Tel: +91(22)66474100. Website: www.unichemlabs.com. CIN: L99999MH1962PLC012451 Statement of Consolidated Assets and Liabilities f Cror. ... Asat Asat Particulars 30th September, 31st March, 2026 2026 Unaudited Audited I.ASSETS Non-current assets (a) Property, plant and equipment 1,117.65 1,135.90 (b) Right-of-use assets 45.09 67.80 (c) Capital work-in-progress 126.40 100.14 (d) Goodwill 1.55 1.55 (e) Other intangible assets 5.28 7.33 (f) Financial assets (i) Investments 0.02 0.02 (ii) Loans 0.10 0.11 (iii) Other financial assets 10.14 8.59 (g) Deferred tax assets (net) 32.90 30.56 (h) Other non-current assets 203.02 184.85 1,542.15 1,536.85 Current assets (a) Inventories 1,083.46 974.97 (b) Financial Assets (i) Trade receivables 985.83 828.58 (ii) Cash and bank balances Cash & cash equivalents 157.01 289.48 Other bank balances 3.36 5.22 (iii) Loans 0.06 0.06 (iv) Other financial assets 19.98 4.42 (c) Other current assets 112.48 94.61 2,362.18 2,197.34 Non-Current Assets held for sale 3.22 3.25 TOTAL ASSETS 3,907.55 3,737.44 II. EQUITY AND LIABILITIES Equity (a) Equity share capital 14.08 14.08 (b) Other equity 2,767.35 2,703.36 2,781.43 2,717.44 Liabilities Non-current liabilities (a) Financial liabilities (i) Borrowings 32.35 39.12 (ii) Lease liabilities 18.21 26.00 (b) Provisions 21.72 28.64 (c) Deferred tax liabilities (net) 52.98 39.88 (d) Other non-current liabilities 0.19 0.42 125.45 134.06 Current liabilities (a) Financial liabilities (i) Borrowings 442.21 429.66 (ii) Lease liabilities 5.49 5.37 (iii) Trade payables Total outstanding dues of micro enterprises 20.93 14.98 and small enterprises Total outstanding dues of creditors other than 432.79 341.65 micro enterprises and small enterprises (iv) Other financial liabilities 36.93 59.66 (b) Other current liabilities 32.53 29.92 (c) Provisions 29.61 4.70 (d) Current tax liabilities (net) 0.18 - 1,000.67 885.94 TOTAL EQUITY AND LIABILITIES 3,907.55 3,737.44 UNll:HEM UNICHEM LABORATORIES LIMITED Regd. Office: 47, Kandivli Industrial Estate, Kandivli (West), Mumbai 400 067, Maharashtra, India. Tel: +91(22)66474100. Website: www.unichemlabs.com. CIN: L99999MH1962PLC012451 Statement of Consolidated Cash Flows f Crores Six months ended Six months ended Particulars 30th September, 2026 30th September, 2025 (Unaudited) (Unaudited) A.Cash Flow from Operating Activities Net Profit I (Loss) before tax 76.36 (19.84) Adjustments: Depreciation / amortisation expense 60.43 63.26 Loss/ (profit) on sale/ surrender /discard of property, plant and equipment (net) (3.75) 0.16 lmpairmement loss on property, plant and equipment - 3.12 Unrealised exchange difference (gain) / loss (net) 6.84 0.69 Gain on sale of subsidiary - (1.99) Rent income * - (0.03) Finance cost 14.13 14.78 Provision for doubtful debts, loans, advances & deposits (net) 1.68 (0.43) Share-based payment to employees 0.16 0.50 Fair value (gain)/loss on investments (net) 1.53 (0.69) Bad debts written off 0.25 - Interest income (0.50) (3.26) Sundry balance written off/ (written back) (1.20) - Provision for European commission fine - 58.26 Provision for Claims 24.26 - Dividend income * - - 103.83 134.37 Operating Profit I (Loss) before Working Capital changes 180.19 114.53 Working Capital Adjustments: Trade receivables & other assets (229.48) 44.23 Inventories (108.49) 10.84 Trade payables & other liabilities 92.9 [Showing first 8,000 characters — download PDF for full document]